Authors: Lalwani, Kush1; Giddabasappa, Anand1; Li, Danan2; Olson, Peter2; Simmons, Brett2; Shojaei, Farbod2; Van Arsdale, Todd2; Christensen, James2; Jackson-Fisher, Amy2; Wong, Anthony3; Lappin, Patrick B3; Eswaraka, Jeetendra4
Source: Comparative Medicine, Volume 63, Number 6, December 2013, pp. 482-490(9)
Document Type: Research Article
Affiliations: 1: Comparative Medicine, Pfizer, San Diego, California 2: Oncology Research Unit, Pfizer, San Diego, California 3: Drug Safety Research and Development, Pfizer, San Diego, California 4: Comparative Medicine, Pfizer, San Diego, California;, Email: Jeetendra.firstname.lastname@example.org
Publication date: December 1, 2013
Comparative Medicine (CM), an international journal of comparative and experimental medicine, is the leading English-language publication in the field and is ranked by the Science Citation Index in the upper third of all scientific journals. The mission of CM is to disseminate high-quality, peer-reviewed information that expands biomedical knowledge and promotes human and animal health through the study of laboratory animal disease, animal models of disease, and basic biologic mechanisms related to disease in people and animals.
Attention Members: To access the full text of the articles, be sure you are logged in to the AALAS website.
Attention: please note, due to a temporary technical problem, reference linking within the content is not available at this time